## **Core Concept**
The question presents a clinical scenario suggestive of a specific immunodeficiency disorder characterized by a triad of symptoms: thrombocytopenia, eczema, and recurrent infections. This combination of symptoms is highly indicative of **Wiskott-Aldrich Syndrome (WAS)**, a rare X-linked recessive disorder.

## **Why the Correct Answer is Right**
Wiskott-Aldrich Syndrome is caused by mutations in the WAS gene, which encodes for the Wiskott-Aldrich syndrome protein (WASp). This protein is crucial for the function of platelets and T lymphocytes. The syndrome classically presents with a triad of:
- **Thrombocytopenia** (low platelet count), often with small platelets, leading to a bleeding tendency.
- **Eczema**, which can range from mild to severe.
- **Recurrent infections**, due to impaired immune function.

The WAS gene mutation affects the cytoskeleton organization in platelets and T cells, impairing their function. This results in the clinical manifestations of the syndrome.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While some primary immunodeficiencies present with recurrent infections, the specific combination of thrombocytopenia, eczema, and recurrent infections is not typical for most of the options listed here, making them less likely.
- **Option B:** Similarly, other immunodeficiencies may present with some overlapping features but not the distinct triad seen in WAS.
- **Option C:** This option might represent another condition but does not specifically match the classic presentation of WAS.
- **Option D:** Given that the correct answer is already identified as , this option does not align with the characteristic features of Wiskott-Aldrich Syndrome.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that Wiskott-Aldrich Syndrome is an **X-linked recessive disorder**, primarily affecting males. Female carriers can exhibit mild symptoms due to X-chromosome inactivation patterns. Early diagnosis is crucial, as management involves treatments like intravenous immunoglobulin (IVIG) for infections, eczema management, and potentially hematopoietic stem cell transplantation (HSCT) for long-term cure.

## **Correct Answer:** . Wiskott-Aldrich Syndrome